Medicine
Arformoterol 15 mcg/2 mL inhalation solution
Arformoterol 15 mcg/2 mL inhalation solution is a generic prescription medicine for inhalation use, made by 15 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store Arformoterol Tartrate Inhalation Solution in the protective foil pouch…
Key facts
- Active ingredient (INN)
- Arformoterol
- Brand
- Sold under the generic name
- Strength
- 15 mcg/2 mL
- Dosage form
- Inhalation solution
- Route
- Inhalation
- Packs
- 30 pouches, 60 pouches, 12 pouches and 28 more
- Manufacturers
- CiplaIndiaAlembic PharmaceuticalsIndiaDr. Reddy's LaboratoriesIndiaLifestar PharmaIndiaLupinIndiaSun Pharmaceutical IndustriesIndiaMicro LabsIndiaRitedose PharmaceuticalsAmerican Health PackagingAucta Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store Arformoterol Tartrate Inhalation Solution in the protective foil pouch under refrigeration at 36°-46°F (2°-8°C). Unopened foil pouches of Arformoterol Tartrate Inhalation Solution can also be stored at room temperature 68°-77°F (20°-25°C) for up to 6 weeks. If stored at room temperature, discard if not used after 6 weeks or if past the expiration date, whichever is sooner.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 22 June 2021
- Identifiers
- RxCUI 668956DailyMed set ID 8c0d81db-fbf5-405f-9311-d3d78992d9a3, 70071afd-5323-4019-aca5-5534278829dc, 6838a595-19cc-454a-96b9-ff83b93881ae +12NDC 73289-0072, 69097-168, 42571-464 +12Application ANDA218380, ANDA207306, ANDA218555 +10
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 pouch in 1 carton / 1 vial in 1 pouch / 2 mL in 1 vial | 62332-633-30 | Alembic PharmaceuticalsIndia | 10 May 2022 |
| 60 pouch in 1 carton / 4 vial in 1 pouch / 2 mL in 1 vial | 62332-633-60 | Alembic PharmaceuticalsIndia | 10 May 2022 |
| 30 pouch in 1 carton / 1 vial, single-dose in 1 pouch / 2 mL in 1 vial, single-dose | 69097-168-53 | CiplaIndia | 27 January 2022 |
| 12 pouch in 1 carton / 5 vial, single-dose in 1 pouch / 2 mL in 1 vial, single-dose | 69097-168-64 | CiplaIndia | 22 June 2021 |
| 6 pouch in 1 carton / 5 vial, single-dose in 1 pouch / 2 mL in 1 vial, single-dose | 69097-168-87 | CiplaIndia | 22 June 2021 |
| 30 pouch in 1 carton / 1 vial, single-dose in 1 pouch / 2 mL in 1 vial, single-dose | 43598-777-30 | Dr. Reddy's LaboratoriesIndia | 2 September 2024 |
| 15 pouch in 1 carton / 4 vial, single-dose in 1 pouch / 2 mL in 1 vial, single-dose | 43598-777-60 | Dr. Reddy's LaboratoriesIndia | 2 September 2024 |
| 60 pouch in 1 carton / 4 vial in 1 pouch / 2 mL in 1 vial | 70756-612-60 | Lifestar PharmaIndia | 15 November 2022 |
| 30 pouch in 1 carton / 1 vial in 1 pouch / 2 mL in 1 vial | 70756-612-70 | Lifestar PharmaIndia | 15 November 2022 |
| 30 pouch in 1 carton / 1 vial, single-dose in 1 pouch / 2 mL in 1 vial, single-dose | 70748-175-30 | LupinIndia | 27 July 2022 |
| 60 pouch in 1 carton / 1 vial, single-dose in 1 pouch / 2 mL in 1 vial, single-dose | 70748-175-60 | LupinIndia | 27 July 2022 |
| 30 pouch in 1 carton / 1 vial in 1 pouch / 2 mL in 1 vial | 42571-464-73 | Micro LabsIndia | 1 May 2025 |
| 6 pouch in 1 carton / 5 vial, single-dose in 1 pouch / 2 mL in 1 vial, single-dose | 62756-277-02 | Sun Pharmaceutical IndustriesIndia | 28 May 2022 |
| 12 pouch in 1 carton / 5 vial, single-dose in 1 pouch / 2 mL in 1 vial, single-dose | 62756-277-03 | Sun Pharmaceutical IndustriesIndia | 28 May 2022 |
| 30 pouch in 1 carton / 1 vial, single-dose in 1 pouch / 2 mL in 1 vial, single-dose | 73289-0072-3 | Aucta Pharmaceuticals | 11 February 2025 |
| 15 pouch in 1 carton / 4 vial, single-dose in 1 pouch / 2 mL in 1 vial, single-dose | 73289-0072-4 | Aucta Pharmaceuticals | 11 February 2025 |
| 60 pouch in 1 carton / 4 vial in 1 pouch / 2 mL in 1 vial | 73043-052-60 | Devatis | 1 August 2025 |
| 30 pouch in 1 carton / 1 vial in 1 pouch / 2 mL in 1 vial | 73043-052-93 | Devatis | 1 August 2025 |
| 30 pouch in 1 carton / 1 vial, single-dose in 1 pouch / 2 mL in 1 vial, single-dose | 72266-259-30 | Fosun Pharma | 8 April 2025 |
| 15 pouch in 1 carton / 4 vial, single-dose in 1 pouch / 2 mL in 1 vial, single-dose | 72266-259-60 | Fosun Pharma | 8 April 2025 |
| 6 pouch in 1 carton / 5 vial, single-dose in 1 pouch / 2 mL in 1 vial, single-dose | 50742-395-30 | Ingenus Pharmaceuticals | 1 March 2025 |
| 12 pouch in 1 carton / 5 vial, single-dose in 1 pouch / 2 mL in 1 vial, single-dose | 50742-395-60 | Ingenus Pharmaceuticals | 1 March 2025 |
| 30 pouch in 1 carton / 1 ampule in 1 pouch / 2 mL in 1 ampule | 76204-026-01 | Ritedose Pharmaceuticals | 27 February 2023 |
| 60 pouch in 1 carton / 1 ampule in 1 pouch / 2 mL in 1 ampule | 76204-026-02 | Ritedose Pharmaceuticals | 27 February 2023 |
| 12 pouch in 1 carton / 5 ampule in 1 pouch / 2 mL in 1 ampule | 76204-026-55 | Ritedose Pharmaceuticals | 27 February 2023 |
| 30 pouch in 1 carton / 1 vial in 1 pouch / 2 mL in 1 vial | 70436-151-57 | Slate Run Pharmaceuticals | 22 June 2021 |
| 15 pouch in 1 carton / 4 vial in 1 pouch / 2 mL in 1 vial | 70436-151-58 | Slate Run Pharmaceuticals | 22 June 2021 |
| 30 pouch in 1 carton / 1 vial, single-dose in 1 pouch / 2 mL in 1 vial, single-dose | 60687-770-83 | American Health Packaging | 1 April 2024 |
| 60 pouch in 1 carton / 1 vial, single-dose in 1 pouch / 2 mL in 1 vial, single-dose | 60687-770-84 | American Health Packaging | 1 April 2024 |
| 30 pouch in 1 carton / 1 vial in 1 pouch / 2 mL in 1 vial | 72603-208-30 | NorthStar RxLLC | 1 June 2024 |
| 60 pouch in 1 carton / 4 vial in 1 pouch / 2 mL in 1 vial | 72603-208-60 | NorthStar RxLLC | 1 June 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 6 October 2006 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Arformoterol is a beta2-adrenergic agonist indicated for long-term, twice daily (morning and evening) administration in the maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema, among other approved uses. MedsAcross supplies Arformoterol for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about ArformoterolFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Arformoterol Tartrate prescribing information (Sun Pharmaceutical Industries) · U.S. National Library of Medicine, DailyMed
Need Arformoterol 15 mcg/2 mL inhalation solution for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.